S
Semra Demir
Researcher at Istanbul University
Publications - 35
Citations - 370
Semra Demir is an academic researcher from Istanbul University. The author has contributed to research in topics: Desensitization (medicine) & Hypersensitivity reaction. The author has an hindex of 9, co-authored 35 publications receiving 236 citations. Previous affiliations of Semra Demir include Health Science University.
Papers
More filters
Journal ArticleDOI
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria.
Emek Kocatürk,Andac Salman,Ivan Cherrez-Ojeda,Paulo Ricardo Criado,Jonny Peter,Elif Comert-Ozer,Mohamed Abuzakouk,Rosana Câmara Agondi,Mona Al-Ahmad,Sabine Altrichter,Rand Arnaout,Luisa Karla de Paula Arruda,Riccardo Asero,Andrea Bauer,Moshe Ben-Shoshan,Jonathan A. Bernstein,Mojca Bizjak,Isabelle Boccon-Gibod,Hanna Bonnekoh,Laurence Bouillet,Zenon Brzoza,Paula J. Busse,Regis A. Campos,Emily Carne,Niall Conlon,Roberta F. Criado,Eduardo Magalhães de Souza Lima,Semra Demir,Joachim Dissemond,Sibel Doğan Günaydın,Irina Dorofeeva,Luis Felipe Ensina,Ragıp Ertaş,Silvia Mariel Ferrucci,Ignasi Figueras-Nart,Daria Fomina,Sylvie M Franken,Atsushi Fukunaga,Ana Giménez-Arnau,Kiran Godse,Margarida Gonçalo,M. Gotua,Clive Grattan,Carole Guillet,Naoko Inomata,Thilo Jakob,Gül Karakaya,Alicja Kasperska-Zając,Constance H. Katelaris,Mitja Košnik,Dorota Krasowska,Kanokvalai Kulthanan,M Sendhil Kumaran,Claudia Lang,José Ignacio Larco-Sousa,E. Lazaridou,Tabi A. Leslie,Undine Lippert,Oscar Calderón Llosa,Michael Makris,A. Marsland,Iris V Medina,R. Y. Meshkova,Esther Bastos Palitot,Claudio A S Parisi,Julia Pickert,German D. Ramon,Mónica Rodríguez-González,Nelson Rosario,Michael Rudenko,Krzysztof Rutkowski,Jorge Sánchez,Sibylle Schliemann,Bulent Enis Sekerel,Faradiba Sarquis Serpa,E Serra-Baldrich,Zhiqiang Song,Angèle Soria,Maria Staevska,Petra Staubach,Anna Tagka,Shunsuke Takahagi,Simon Francis Thomsen,Regina Treudler,Zahava Vadasz,Solange Oliveira Rodrigues Valle,Martijn B. A. van Doorn,Christian Vestergaard,Nicola Wagner,Dahu Wang,Liangchun Wang,Bettina Wedi,Paraskevi Xepapadaki,Esra Yücel,Anna Zalewska-Janowska,Zuotao Zhao,Torsten Zuberbier,Marcus Maurer +97 more
TL;DR: The COVID‐19 pandemic dramatically disrupts health care around the globe and the impact of the pandemic on chronic urticaria and its management are largely unknown.
Journal ArticleDOI
Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients:
Semra Demir,Bahar Artim-Esen,Yasemin Şahinkaya,Özlem Pehlivan,N Alpay-Kanıtez,Ahmet Omma,Burak Erer,Sevil Kamali,Ahmet Gül,Orhan Aral,Lale Ocal,Murat Inanc +11 more
TL;DR: The prevention of MetS and long-term use of HCQ may be beneficial in improving the prognosis of SLE and Hydroxychloroquine use was found as a protective factor for CVD.
Journal ArticleDOI
Evaluation of hypersensitivity reactions to nonsteroidal anti-inflammatory drugs according to the latest classification.
TL;DR: Evaluating the usability of the latest NSAID hypersensitivity classification of ENDA found it to be suitable for use in patients with high hypersensitivity to NSAIDs.
Journal ArticleDOI
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
Sedat Sen,Rana Karabudak,Irene Schiavetti,Semra Demir,Serkan Ozakbas,Melih Tutuncu,B. Petek Balci,Ömer Faruk Turan,Cihat Uzunköprü,Mesrure Koseoglu,Mehmet Fatih Yetkin,Tuncay Gündüz,Haluk Gümüş,N. Kale Icen,Luca Carmisciano,Murat Terzi,Pinar Acar,I. Gungor Dogan,Cavid Baba,Aslı Tuncer,Ugur Uygunoglu,M. P. Sormani,Husnu Efendi,Aksel Siva +23 more
TL;DR: In this paper, the authors investigated the relationship between demographic-clinical and therapeutic features and the outcome of Covid-19 infection in a multi-center national cohort of multiple sclerosis patients.
Journal ArticleDOI
Usefulness of In Vivo and In Vitro Diagnostic Tests in the Diagnosis of Hypersensitivity Reactions to Quinolones and in the Evaluation of Cross-Reactivity: A Comprehensive Study Including the Latest Quinolone Gemifloxacin.
Semra Demir,Aslı Gelincik,Nilgun Akdeniz,Esin Aktas-Cetin,Muge Olgac,Derya Unal,Belkıs Ertek,Raif Coskun,Bahattin Çolakoğlu,Günnur Deniz,Suna Büyüköztürk +10 more
TL;DR: STs, BAT, and LTT are not supportive in the diagnosis of a hypersensitivity reaction to quinolone as well as in the prediction of cross-reactivity.